Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty
NCT00744796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2020-12-11
Summary
The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging modalities available for the anterior segment.
Conditions
- Corneal Edema Secondary to Corneal Endothelial Dystrophy
Interventions
- PROCEDURE
-
DSAEK
Endothelial Keratoplasty
- DIAGNOSTIC_TEST
-
Anterior Segment Optical Coherence Topography (OCT)
Non-contact, high resolution, cross sectional imaging of the anterior segment of the eye.
- DIAGNOSTIC_TEST
-
Best Spectacle Corrected Visual Acuity (BSCVA)
Visual acuity determined using a combination of detecting hand motion, counting fingers displayed and reading Snellen charts at specific distances.
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Principal Investigators
-
Vinod Mootha, MD · UTSW Medical Center at Dallas
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-07-31
- Completion
- 2009-07-31
Countries
- United States
Study Locations
More Related Trials
-
Visual Enhancement Device in Low Vision Patients
NCT03794752 ·Status: TERMINATED ·Phase: NA
-
Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy
NCT01196325 ·Status: UNKNOWN
-
A Comparison of Visual Functions and Side-effects After DSAEK or DMEK for Fuchs' Endothelial Dystrophy
NCT04417959 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
NCT00799227 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density
NCT03361709 ·Status: WITHDRAWN ·Phase: PHASE4
-
Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK
NCT06652321 ·Status: RECRUITING ·Phase: NA
-
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
NCT03590444 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Intravitreal Ozurdex Implant in DME
NCT03475407 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
NCT02995746 ·Status: TERMINATED ·Phase: NA
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema
NCT03571659 ·Status: COMPLETED
-
Laser and Antioxidant Treatment of Diabetic Macular Edema
NCT00055042 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK
NCT05587231 ·Status: UNKNOWN ·Phase: PHASE4
-
Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)
NCT01030601 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Follow-Up of Diabetic Retinopathy
NCT00001395 ·Status: COMPLETED
-
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema
NCT05728476 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
NCT06984822 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Effect of Conbercept Intravitreal Injection at the Conclusion of Cataract Surgery for Diabetic Macular Edema
NCT04668703 ·Status: UNKNOWN ·Phase: NA
-
Ozurdex in Suboptimal Diabetic Macular Edema Patients
NCT04856397 ·Status: UNKNOWN ·Phase: NA
-
Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema
NCT03598205 ·Status: COMPLETED ·Phase: NA
-
International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients
NCT02639507 ·Status: COMPLETED
-
Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
NCT00371410 ·Status: COMPLETED ·Phase: PHASE1
-
Cell Therapy for Corneal Endothelial Cell Dysfunction
NCT06726174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
OCTA in Epivascular Glia After Dex Implant
NCT05600179 ·Status: COMPLETED